In Treatment

You are here

In Treatment

If you have been NEWLY DIAGNOSED  START HERE 

Video Library

ASCO 2018 - Will Taking Mod to High Dose Steroids Affect Lung Cancer Patients on Immunotherapy?
Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Non Small Cell Lung Cancer, Pain Medication, Immunotherapies
ASCO 2018 Roundtable - Checkmate 227 - Combinations of Nivolumab and Ipilimumab, or Nivolumab and and Chemo
Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Non Small Cell Lung Cancer, Chemotherapy, Immunotherapies
,
,
,
,
Clinical Care Options 2018 - Measurable Residual Disease in Acute Lymphoblastic Leukemia
GRACE has partnered with Clinical Care Options (CCO) Oncology, to share a series of educational videos regarding Measurable Residual Disease (MRD) in acute lymphocytic leukemia (ALL).
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Blood Cancers
Disease Learning:
Chronic Lymphocytic Leukemia, General Blood Cancer, Stem Cell Transplant, Targeted Therapies Blood, Mantle Cell Lymphoma, Non-Hodgkin Lymphoma
,
,
,
,
OncTalk 2018 - Local Therapies for Metastatic Lung Cancer - Who, What, Why, When and How?
On Saturday, November 10, 2018, GRACE partnered with Swedish Cancer Institute to present a discussion on Local Therapies for Metastatic Lung Cancer...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Scans - PET-CT, etc., Radiation Therapy, Surgical, Chemotherapy, Non Small Cell Lung Cancer, Immunotherapies
GRACE & Living Yoga Therapy Present: Living Through Cancer and Managing Anger
GRACE is excited to bring to you more in our new series on surviving with cancer GRACE is excited to bring to you more in our series on surviving...
Cancer Journey:
Just Diagnosed, In Treatment, In Remission, Survivorship
Cancer Type:
Lung Cancer, Blood Cancers, Head and Neck Cancer, Other
Disease Learning:

Articles

Head & Neck Cancers - Frequently Asked Questions
Head & Neck Cancers Frequently Asked Questions Written by Joshua Bauml, MD September 2017 What is it? “Head and neck cancer” is an umbrella term...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Head and Neck Cancer
Disease Learning:
General Head and Neck Cancer
Progress in Understanding DNA Changes in Lymphoma
Malignant Hematology Progress in understanding DNA changes in lymphoma has already provided improved and highly sensitive tests for detecting this...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Blood Cancers
Disease Learning:
Non-Hodgkin Lymphoma, Mantle Cell Lymphoma, General Blood Cancer
Why I Don't Favor a Front-Loaded Approach for Most Advanced NSCLC Patients
To many, the recent FDA approval of a combination of chemotherapy and concurrent immunotherapy for the vast majority of patients with advanced (metastatic) non-squamous non-small cell lung cancer (NSCLC) probably seems like a great idea.
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Why Carboplatin, Pemetrexed and Pembrolizumab Have Become My New Go-to Regimen for First-Line Non-Squamous NSCLC Treatment
Dr. Jonathan Goldman joins GRACE to explain why carboplatin, pemetrexed and pembrolizumab has become his new go-to regimen for first-line non-squamous NSCLC treatment.
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
My Top 10 ASCO 2017 Lung Cancer Presentations
Over the next few days, about 30,000 oncologists and other cancer care professionals, along with a growing number of patient advocates, are...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Non Small Cell Lung Cancer, Small Cell Lung Cancer

Community Forum

Local Therapies for Metastatic Lung Cancer Who, What, Why, When and How?
Hi Grace Members, Grace is happy to present in partnership with the Swedish Cancer Institute " Local Therapies for Metastatic Lung Cancer Who,...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, Drugs, Targeted Therapies – ALK, Targeted Therapies - EGFR, Targeted Therapies – ROS1, Procedures & Treatments, Chemotherapy, Tumor Marker Tests, Targeted Therapy, Investigational Agents, Immunotherapies, Radiation Therapy, Non Small Cell Lung Cancer
Progression on Tarceva - T790m negative
Progression after 3 1/2 years on Tarceva. Tissue biopsy showed T790m negative. Any suggestions/experience on next steps? Onc suggesting I move to Afatinib or a Opdivo. PDL1 was tested and is <1%.
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, General Lung Cancer, Targeted Therapies - EGFR, Targeted Therapy, Molecular Testing, Immunotherapies, Non Small Cell Lung Cancer
Keytruda for Adenocarcinoma (NSCLC), first PET-CT result
Hello friends, My mom, (aged 77, Adenocarcinoma NSCLC, Stage 4, EGFR and ALK negative) was diagnosed in 2014, underwent VATS and pleurodesis,...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, General Lung Cancer, Immunotherapies, Non Small Cell Lung Cancer
Stage IIIb ALK NSCLC first line treatment
This question is not for a specific patient, it is designed to understand how oncologists would approach this problem. There’s a 50 year old stage...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapies – ALK, Non Small Cell Lung Cancer
Tough decision between a whole brain radiation vs occipital craniotomy
My wife is experiencing a second time brain tumor recurrence. She had her first occipital craniotomy back in 2011. On late Oct 2013 she began to...
Cancer Journey:
In Treatment, Survivorship
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, General Lung Cancer, Symptoms, Pain Medication, Procedures & Treatments, Maintenance Therapy, Radiation Therapy, Non Small Cell Lung Cancer